ABSTRACT
African horse sickness (AHS) was induced in five horses by inoculation, to determine the ultrastructural changes in endothelial cells of capillaries in the myocardium, lung, spleen and liver. The animals developed cardiac and mixed forms of the disease. Alterations detected in the endothelial cells of the vessels of infected animals included: the presence of structures associated with viral infection, hypertrophy, degenerative changes, appearance of cytoplasmic projections, changes in permeability, alteration of intercellular junctions, loss of endothelium, subendothelial deposition of cell debris and fibrin, and vascular repair. In association with these changes, oedema, haemorrhages and microthromboses were detected, particularly in the myocardium and lung. This study showed that infection of, and changes to, the capillary endothelial cells of the organs under study was independent of the form in which the disease manifested itself but was dependent on the organ and blood vessel type. Thus, different levels of viral tropism were observed for the endothelial cells of the vessels in different organs. Viral infection was commonest in the endothelial cells of myocardial vessels, followed by those in the lung, whereas in the spleen and liver, endothelial cell infection was rare and, in the case of the liver, limited to the interstitial capillaries.
Subject(s)
African Horse Sickness/pathology , Capillaries/ultrastructure , Endothelium, Vascular/pathology , Animals , Capillaries/pathology , Capillary Permeability , Cytopathogenic Effect, Viral , Cytoplasm/ultrastructure , Endothelium, Vascular/ultrastructure , Female , Horses , Intercellular Junctions/ultrastructure , Liver/blood supply , Liver/ultrastructure , Lung/blood supply , Lung/ultrastructure , Myocardium/pathology , Myocardium/ultrastructure , Spleen/blood supply , Spleen/ultrastructureABSTRACT
African horse sickness (AHS) is a disease of equids, characterized by severe pulmonary oedema and caused by an orbivirus. To determine the role of pulmonary intravascular macrophages (PIMs) in the development of pulmonary microvascular changes in this disease, five horses were given an intravenous inoculation of 10(6)TCID50of serotype 4 of AHS virus. Viral replication was detected in endothelial cells, PIMs, interstitial macrophages and fibroblasts. Alveolar and interstitial oedema, and changes in pulmonary microvasculature, consisting mainly of the sequestration of neutrophils and the formation of platelet aggregates and fibrinous microthrombi, were related to endothelial changes and to a high degree of PIM activation. This suggested that the PIMs, once activated, contributed to these vascular changes by releasing chemical inflammatory mediators.
Subject(s)
African Horse Sickness/pathology , Macrophages, Alveolar/physiology , Orbivirus , African Horse Sickness/virology , Animals , Cytopathogenic Effect, Viral , Endothelium, Vascular/pathology , Endothelium, Vascular/virology , Female , Horses , Lung/blood supply , Lung/pathology , Macrophages, Alveolar/virology , Microscopy, Electron, Scanning Transmission , Orbivirus/isolation & purification , Virus ReplicationABSTRACT
Two groups, comprising 4 donkeys and 4 mules (group 1) and 4 donkeys and 3 mules (group 2), were used to determine the duration of viraemia and to monitor the development of antibodies following inoculation with African horse sickness virus (AHSV). One group of animals was given a single dose of attenuated AHSV serotype 4 (AHSV 4) vaccine. The second group was inoculated with a virulent field strain of AHSV 4. Both groups were subsequently challenged with the virulent field strain of AHSV 4, 51 and 58 days, respectively, after their primary inoculation. Blood and serum samples, collected on alternate days after the primary inoculations and also after subsequent challenge, were assayed for virus and antibodies. Seven of the 8 AHSV vaccinated (group 1) and 7 of the 7 AHSV inoculated (group 2) animals showed humoral antibody responses after primary inoculation. Although no infectious virus could be isolated from either group for the duration of the study, reverse transcription-PCR data obtained for the second group did show the presence of AHSV viral RNA from as early as day 5 in mules and day 9 in donkeys after the primary inoculation. Viral RNA was detected consistently up to day 47 in some animals and intermittently thereafter. There was no evidence of a second viraemia in any of the animals after challenge. The detection of specific antibodies, against AHSV 4 NS3 protein, in all animals confirmed that both donkeys and mules were infected and that the virus had replicated.
Subject(s)
African Horse Sickness Virus/immunology , African Horse Sickness/immunology , Antibodies, Viral/blood , Equidae , Viremia/veterinary , African Horse Sickness/virology , African Horse Sickness Virus/genetics , African Horse Sickness Virus/pathogenicity , Animals , Enzyme-Linked Immunosorbent Assay/veterinary , Neutralization Tests/veterinary , Polymerase Chain Reaction/veterinary , RNA, Viral/blood , Vaccines, Attenuated/immunology , Viral Vaccines/immunology , Viremia/immunology , Viremia/virology , VirulenceABSTRACT
The mortality rate in susceptible populations of horses during an epizootic of African horse sickness (AHS) may be in excess of 90%. Rapid and reliable assays are therefore essential for the confirmation of clinical diagnoses and to enable control strategies to be implemented without undue delay. One of the major objectives of a recent European Union funded project was the validation of newly developed diagnostic assays which are rapid, sensitive, highly reproducible and inexpensive, for the detection of African horse sickness virus (AHSV) antigens and antibodies. The Laboratorio de Sanidad y Produccion Animal (LSPA) in Algete, Spain was charged with the responsibility of co-ordinating and supplying samples of viruses and antisera to the participating laboratories in Spain, France and the United Kingdom. The panels comprised 76 antigen samples for assay by indirect sandwich ELISAs and 53 serum samples for antibody detection by either indirect or competitive ELISAs. Results generated by ELISA for each laboratory were analysed in LSPA in terms of their relative sensitivities and specificities. There was a good agreement between the ELISAs used for either antigen or antibody detection. The participating groups agreed that any field sample giving a doubtful result would always be retested by ELISA and an alternative assay.
Subject(s)
African Horse Sickness Virus/immunology , African Horse Sickness/diagnosis , Antibodies, Viral/blood , Antigens, Viral/analysis , Enzyme-Linked Immunosorbent Assay/veterinary , African Horse Sickness/immunology , Animals , Cattle , Enzyme-Linked Immunosorbent Assay/methods , Guinea Pigs , Horses , Immune Sera/immunology , Mice , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection.
Subject(s)
African Horse Sickness Virus/immunology , African Horse Sickness/immunology , Antibodies, Viral/blood , Antigens, Viral , Capsid Proteins , Animals , Blotting, Western , Capsid/immunology , Vaccination , Viral Proteins/immunology , Viral Vaccines/immunologyABSTRACT
African horsesickness virus serotype 4 (AHSV-4) outer capsid protein VP2, or VP2 and VP5 plus inner capsid protein VP7, derived from single or dual recombinant baculovirus expression vectors were used in different combinations to immunize horses. When the proteins were purified by affinity chromatography, the combination of all three proteins induced low levels of neutralizing antibodies and conferred protection against virulent virus challenge. However, purified VP2 or VP2 and VP5 in the absence of VP7 failed to induce neutralizing antibodies and protection. Immunization with non-purified proteins enhanced the titres of neutralizing antibodies. Again, the combination of the three proteins was able to confer total protection to immunized horses, which showed absence of viraemia. The antigenicity of recombinant VP2 was analysed with a collection of 30 MAbs. Both purified and unpurified recombinant VP2 proteins showed different antigenic patterns in comparison to that of VP2 on virions. An immunization experiment with four more horses confirmed these results. The vaccine described here would not only prevent the disease, but would drastically reduce the propagation of the virus by vectors.
Subject(s)
African Horse Sickness Virus/immunology , African Horse Sickness/immunology , African Horse Sickness/prevention & control , Antigens, Viral/immunology , Capsid/immunology , Vaccines, Synthetic , Viral Vaccines , Animals , Antibodies, Viral/biosynthesis , Antibodies, Viral/blood , Antigens, Viral/biosynthesis , Baculoviridae , Capsid/biosynthesis , Chlorocebus aethiops , Enzyme-Linked Immunosorbent Assay , Horses , Neutralization Tests , Spodoptera , Vero CellsABSTRACT
Segment 10 of the double-stranded RNA (dsRNA) genome from African horse sickness virus serotype 4 (AHSV-4) was cloned and sequenced. The sequence of the coding region showed a total length of 667 bp. Nucleotide comparisons showed a 95% sequence similarity between serotypes 4 and 9, and 76% between serotypes 4 and 3. cDNA clones containing the coding region were cloned in the vector pET3xb and expressed in Escherichia coli. The NS3 gene product was synthesised at very high level as an insoluble fusion protein. The recombinant protein was used in a differential ELISA to distinguish horses that were infected with AHSV-4 or vaccinated with live-modified virus from those vaccinated with a purified inactivated vaccine. The results obtained indicate that recombinant NS3 can indeed differentiate between infected and vaccinated animals implying that this recombinant could be developed as a diagnostic reagent, and it would allow the mobility of vaccinated horses. Thus, economical losses associated with this disease could be avoided.
Subject(s)
African Horse Sickness Virus/genetics , African Horse Sickness Virus/immunology , African Horse Sickness/immunology , Viral Nonstructural Proteins/genetics , African Horse Sickness/diagnosis , African Horse Sickness/virology , Amino Acid Sequence , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Base Sequence , Chlorocebus aethiops , Cloning, Molecular , DNA, Viral , Enzyme-Linked Immunosorbent Assay/veterinary , Escherichia coli/genetics , Genetic Vectors , Molecular Sequence Data , RNA, Viral , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Sequence Homology, Amino Acid , Vaccination/veterinary , Vero Cells , Viral Nonstructural Proteins/immunologyABSTRACT
The structural and non-structural proteins induced by African horsesickness virus serotype 4 (AHSV-4) in infected Vero cells were analysed by SDS-PAGE. Twenty-two virus-induced polypeptides were detected in infected cells by comparison with the polypeptides of mock-infected cells, of which four major (VP2, VP3, VP5 and VP7) and three minor (VP1, VP4 and VP6) structural proteins and four non-structural proteins (P58, P48, P21 and P20) were shown to be virus-coded, as deduced from electrophoretic and antigenic studies of purified virions and infected cells. The proteins that elicit the major antibody responses both in vaccinated and naturally or experimentally infected horses were shown to be three structural proteins, VP2, VP5 and VP7, and the four major non-structural proteins, P58, P48, P21 and P20, as deduced by radioimmunoprecipitation and immunoblotting assays. The cross-reactivity between AHSV-4 and sera obtained from horses experimentally infected with seven other serotypes was also determined. The results showed that VP5, VP7, P48, P21 and P20 are conserved and can be used to diagnose the infection of any of these eight serotypes.
Subject(s)
African Horse Sickness Virus/chemistry , Peptides/analysis , Viral Proteins/analysis , African Horse Sickness/diagnosis , African Horse Sickness Virus/classification , Animals , Antibodies, Viral/blood , Blotting, Western , Cross Reactions , Horses , Serologic Tests , Serotyping , Vero CellsABSTRACT
The epitope specificity of the protective immune response against swine transmissible gastroenteritis (TGE) has been investigated by using circulating and secretory antibodies. This study was carried out with sows vaccinated with TGEV or the antigenically related porcine respiratory coronavirus (PRCV). TGEV vaccination of sows resulted in greater lactogenic protection of suckling piglets against TGEV challenge and a higher secretory immune response than PRCV vaccination did. These differences in the immune response were conditioned by the route of antigen presentation as a result of the different tropism of each virus. Epitopes on S protein, and in particular those contained in its antigenic site. A, were more immunogenic than epitopes on N and M proteins in both groups of vaccinated sows, as determined by a competitive radioimmunoassay. Minor differences in antibody response against the previously defined antigenic subsites Aa, Ab, and Ac were also detected, with subsite Ab being the most antigenic in both TGEV- and PRCV-immune sows. These findings suggest that antigenic site A on S protein, involved in virus neutralization, is the immunodominant site in pregnant sows that confer lactogenic protection. They also validate, in experiments with secretory antibodies, the antigenic maps made with murine monoclonal antibodies. Therefore, this antigenic site should be considered for vaccine or diagnostic development.
Subject(s)
Antibodies, Viral/immunology , Epitopes/immunology , Gastroenteritis, Transmissible, of Swine/immunology , Immunity, Maternally-Acquired/immunology , Milk/immunology , Animals , Animals, Suckling/immunology , Antibodies, Viral/blood , Antibody Formation , Cells, Cultured , Female , Male , Swine , Testis/cytology , Vaccination , Viral Proteins/immunologyABSTRACT
A sandwich enzyme-linked immunsorbent assay (ELISA) for rapid detection of African horsesickness virus (AHSV) in infected spleens or cell culture supernatant was developed. This method uses two monoclonal antibodies (MAbs) which recognize two non-overlapping epitopes of the major core protein (VP7) to coat the solid phase, and one labeled with biotin as second antibody. This ELISA was evaluated for its ability to detect AHSV in infected spleens resulting in a sensitivity of 97.4% and a specificity of 100% compared with virus isolation in cell culture, and can be used for the detection of the nine different AHSV serotypes.
Subject(s)
African Horse Sickness Virus/isolation & purification , African Horse Sickness/diagnosis , Antigens, Viral , Capsid Proteins , Capsid/immunology , Enzyme-Linked Immunosorbent Assay/methods , Spleen/microbiology , Animals , Antibodies, Monoclonal , Antibodies, Viral , Avidin , Biotin , Capsid/isolation & purification , Horses , Sensitivity and SpecificityABSTRACT
The major core protein, VP7, of African horsesickness virus serotype 4 (AHSV-4), the aetiological agent of a recent outbreak of the disease in southern Europe, was expressed in insect cells infected with a recombinant baculovirus containing a cloned copy of the relevant AHSV gene (S7). Analyses of its biochemical and antigenic properties confirmed the authenticity of the protein expressed. The high-level expression of VP7 under the control of the strong polyhedrin promoter of Autographa californica nuclear polyhedrosis virus induced disc-shaped crystals in infected insect cells. This enabled us to purify the protein by a one-step ultracentrifugation procedure and to utilize it for the detection of antibodies raised in horses to various serotypes of AHSV. A serological relationship between AHSV and two other orbiviruses, bluetongue virus and epizootic haemorrhagic disease virus, was also demonstrated.
Subject(s)
African Horse Sickness Virus/immunology , African Horse Sickness/diagnosis , Antigens, Viral/biosynthesis , Viral Core Proteins/biosynthesis , African Horse Sickness Virus/genetics , Animals , Antigens, Viral/immunology , Baculoviridae/genetics , Base Sequence , Cells, Cultured , Cross Reactions , Epitopes/immunology , Genetic Vectors , Molecular Sequence Data , Recombinant Proteins/biosynthesis , Recombination, Genetic , Reoviridae/immunology , Serotyping , Viral Core Proteins/genetics , Viral Core Proteins/immunologyABSTRACT
Four virus-induced non-structural proteins with apparent molecular weights of 11-14 kilodaltons (kDa) were identified by two-dimensional electrophoresis in cells infected by TGEV. Differences in the number of non-structural proteins were observed among virulent and attenuated TGEV strains as well as with two antigenically related feline and canine coronaviruses.
Subject(s)
Gastroenteritis, Transmissible, of Swine/genetics , RNA, Messenger/genetics , Transmissible gastroenteritis virus/genetics , Viral Proteins/genetics , Animals , Cats , Cells, Cultured , Coronaviridae/genetics , Dog Diseases/microbiology , Dogs , Electrophoresis, Gel, Two-Dimensional , Feline Panleukopenia Virus/genetics , Male , Swine , Testis/cytologyABSTRACT
The peplomer protein (S) and the transmembrane protein (M) of transmissible gastroenteritis virus (TGEV) of swine were identified by iodination and serologically on the surface of infected cells. Of a total of 4 monoclonal antibodies (mAb) directed against four antigenic sites of S protein (Correa et al., 1988), 3 specific for sites A, B and D attached to the plasma membrane of infected cells, as disclosed by indirect immunofluorescence and by complement-mediated cytolysis. Four of the mAbs assayed were specific for the viral protein M and two of them gave plasma membrane immunofluorescence and mediated cytolysis in the presence of complement. The viral nucleoprotein N could not be demonstrated on the surface of infected cells either by iodination or employing 3 mAbs against this protein. Finally, a time course infection experiment demonstrated that S and M proteins were expressed on the surface of infected cells at 4 h after infection, before infective virus was released from infected cells.
Subject(s)
Antigens, Surface/immunology , Antigens, Viral/immunology , Epitopes/immunology , Gastroenteritis, Transmissible, of Swine/immunology , Viral Envelope Proteins/immunology , Animals , Antibodies, Monoclonal , Antibody-Dependent Cell Cytotoxicity , Antigens, Surface/biosynthesis , Antigens, Viral/biosynthesis , Cell Membrane/immunology , Electrophoresis, Polyacrylamide Gel , Fluorescent Antibody Technique , Male , Swine , Testis/immunology , Testis/ultrastructure , Viral Envelope Proteins/biosynthesisABSTRACT
The antigenic homology of 26 coronavirus isolates, of which 22 were antigenically related to transmissible gastroenteritis virus (TGEV), was determined with 42 monoclonal antibodies. Type, group, and interspecies specific epitopes were defined. Two group specific MAbs distinguished the enteric TGEV isolates from the respiratory variants. An antigenic subsite involved in neutralization was conserved in porcine, feline, and canine coronavirus. The classification of the human coronavirus 229E in a taxonomic cluster distinct from TGEV group is suggested.
Subject(s)
Antigens, Viral/analysis , Coronaviridae/genetics , Coronaviridae/immunology , Transmissible gastroenteritis virus/immunology , Animals , Antibodies, Monoclonal , Coronaviridae/classification , Epitopes/analysis , Swine , Viral Structural Proteins/analysisABSTRACT
The presence of antibodies to two influenza viruses of the type A (H1N1 and H3N2) and to a porcine respiratory coronavirus was investigated in a study lasting a year. 735 blood serum samples were collected from 79 closed pig fattening farms in the province Segovia (Spain). Hemagglutination inhibition was used with influenza viruses. The percentage of positive results was 78.5% and 62.5% respectively for the serotypes H1N1 and H3N2. A clear reduction in the spread of antibodies was observed in the autumn. The ELISA technique was used with the porcine respiratory coronavirus. As antigen we used the antigenically related transmissible porcine gastroenteritis virus. Using this technique 87% of the sera were positive. Some of these sera with representative ELISA values were confirmed by means of serum neutralisation and radioimmune precipitation of the viral proteins. The incidence of these antibodies remained unchanged over the whole year of the investigation.
Subject(s)
Antibodies, Viral/analysis , Coronaviridae/immunology , Influenza A virus/immunology , Swine Diseases/epidemiology , Animals , Coronaviridae Infections/epidemiology , Coronaviridae Infections/veterinary , Orthomyxoviridae Infections/epidemiology , Orthomyxoviridae Infections/veterinary , Prevalence , Spain , SwineABSTRACT
An immunoblotting assay has been adapted to detect antibodies against African swine fever virus. The electrophoretic transfer of proteins and the immunoreaction conditions were optimized, using 4 mA/cm2 of current intensity and 10 micrograms of soluble cytoplasmic antigen of infected cells per strip. Filters of polyvinylidene difluoride showed the highest capacity for protein absorption, but nitrocellulose filters showed lower backgrounds. The specificity and the pattern of the proteins induced by African swine fever virus that react with the antisera were determined in immunoblotting assay, IP30 being the most reactive protein.